Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response"

Antimicrob Agents Chemother. 2014;58(1):629-30. doi: 10.1128/AAC.01651-13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / pharmacokinetics*
  • Female
  • Humans
  • Isoniazid / pharmacokinetics*
  • Male
  • Pyrazinamide / pharmacokinetics*
  • Rifampin / pharmacokinetics*
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Isoniazid
  • Rifampin